Aphios Granted United States Patent for Oral Delivery of Cannabinoids Such as ?9-THC in Nanoparticles
Published: Nov 04, 2013
WOBURN, Mass.--(BUSINESS WIRE)--Aphios Corporation today announced that it received notification of allowance for a United States Patent entitled “Nanoencapsulated Delta-9-Tetrahydrocannabinol” for the oral delivery of cannabinoids such as ?9-THC in biodegradable polymer nanoparticles.
Help employers find you! Check out all the jobs and post your resume.